Jul 12, 2024 / 07:00AM GMT
Matts Johansen - Aker Biomarine ASA - Chief Executive Officer
Good morning, and welcome to the presentation of the second quarter result for Aker Biomarine . Very myself, Matts Johansen the CEO, and the CFO Katrine Klaveness will take you through the highlights and the financials of the quarter. We will also end the session with a Q&A session. And you can already now start sending in questions to ir@aker Biomarine .com.
So the main event of the last period is the sale of the feed ingredient business that we concluded last week valued at $590 million according to accounting rules already now in the second quarter, the feed ingredient business will be classified as held-for-sale or discontinued business. I'm a bit taken out of many of the constant statements you will see in our financial report. We'll get back to the transaction a little bit later.
When talking about the overall business of Aker Biomarine , it's great to be here again now for the eighth quarter in a row and percent growth year-over-year. We delivered $94 million of revenue and $29 million of EBITDA. And the growth
Q2 2024 Aker Biomarine ASA Earnings Call Transcript
Jul 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers